Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.

ABSTRACT:

Background

Malaria is a leading cause of morbidity and mortality among HIV-infected pregnant women in sub-Saharan Africa: at least 1 million pregnancies among HIV-infected women are complicated by co-infection with malaria annually, leading to increased risk of premature delivery, severe anaemia, delivery of low birth weight infants, and maternal death. Current guidelines recommend either daily cotrimoxazole (CTX) or intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) for HIV-infected pregnant women to prevent malaria and its complications. The cost-effectiveness of CTX compared to IPTp-SP among HIV-infected pregnant women was assessed.

Methods

A microsimulation model of malaria and HIV among pregnant women in five malaria-endemic countries in sub-Saha

SUBMITTER: Choi SE 

PROVIDER: S-EPMC6389090 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature